Fig. 1
From: Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment
Engineered MSCs exert therapeutic effects on target organs, especially the lungs. Engineered MSC-exos can exert therapeutic effects on organs such as kidneys, bones, lungs, liver, and stomach, and these therapeutic effects can have multiple targets. For example, in the lungs, engineered MSCs can improve the condition of pulmonary blood vessels, airways, and the lung epithelium